Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder
Sumiyoshi Y, Yokota K, Akiyama M, et al.: Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder. J Urol 152: 362-366, 1994
Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer
Naito S, Kuroiwa T, Ueda T, et al.: Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. J Urol 154: 1704-1709, 1995
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastatis
Logothetis CJ, Samuels ML, Ogden S, et al.: Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastatis. J Urol 134: 460-464, 1985
Preliminary results of M-VAC (methotorexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of urothelium
Sternberg CN, Yagoda A, Scher HI, et al.: Preliminary results of M-VAC (methotorexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of urothelium. J Urol 133: 403-407, 1985
The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer : A prospective comparative trial
Skinner DG, Daniels JR, Russell CA, et al.: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer : a prospective comparative trial. J Urol 145: 459-467, 1991